{"podcast":{"title":"Lung Cancer Update","slug":"lung-cancer-update-827388","podcast_index_feed_id":827388,"rss_url":"https://feeds.captivate.fm/lung-cancer-update/","website_url":"https://www.researchtopractice.com/browse-tumor-types/lung-cancer","image_url":"https://artwork.captivate.fm/230421a8-7e2e-4fb0-b40c-3b50a1cbf78f/nstTehQJgx-Rm0qFgD_28hl9.png","author":"Dr. Neil Love","episode_count":56,"summary":"Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.","last_synced_at":"2026-07-15T06:20:06.840223+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-update-827388"},"episode":{"title":"First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor","slug":"first-line-therapy-for-metastatic-non-small-cell-lung-cancer-and-an-alk-rearrangement-an-interview-with-dr-justin-f-gainor","published_at":"2025-04-10T19:13:00+00:00","page_url":"https://stenobird.com/podcast/lung-cancer-update-827388/first-line-therapy-for-metastatic-non-small-cell-lung-cancer-and-an-alk-rearrangement-an-interview-with-dr-justin-f-gainor","show_page_url":"https://stenobird.com/podcast/lung-cancer-update-827388","url":"https://lung-cancer-update.captivate.fm/episode/5293-firstlinetherapyalkmnsclc24","audio_url":"https://dts.podtrac.com/redirect.mp3/podcasts.captivate.fm/media/6aaf6f8a-150e-4400-9c10-9c57425999c7/FirstLineTherapyALKmNSCLC24-converted.mp3","summary":"Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer.  CME information and select publications here .","meta_description":"Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3448,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/lung-cancer-update-827388/episodes/first-line-therapy-for-metastatic-non-small-cell-lung-cancer-and-an-alk-rearrangement-an-interview-with-dr-justin-f-gainor/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/lung-cancer-update-827388/first-line-therapy-for-metastatic-non-small-cell-lung-cancer-and-an-alk-rearrangement-an-interview-with-dr-justin-f-gainor.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}